全文获取类型
收费全文 | 2757篇 |
免费 | 266篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 280篇 |
妇产科学 | 41篇 |
基础医学 | 169篇 |
口腔科学 | 54篇 |
临床医学 | 226篇 |
内科学 | 706篇 |
皮肤病学 | 46篇 |
神经病学 | 325篇 |
特种医学 | 18篇 |
外国民族医学 | 1篇 |
外科学 | 151篇 |
综合类 | 168篇 |
现状与发展 | 1篇 |
预防医学 | 89篇 |
眼科学 | 14篇 |
药学 | 314篇 |
2篇 | |
中国医学 | 40篇 |
肿瘤学 | 409篇 |
出版年
2024年 | 5篇 |
2023年 | 50篇 |
2022年 | 41篇 |
2021年 | 95篇 |
2020年 | 98篇 |
2019年 | 121篇 |
2018年 | 117篇 |
2017年 | 132篇 |
2016年 | 122篇 |
2015年 | 114篇 |
2014年 | 171篇 |
2013年 | 314篇 |
2012年 | 131篇 |
2011年 | 163篇 |
2010年 | 119篇 |
2009年 | 135篇 |
2008年 | 126篇 |
2007年 | 99篇 |
2006年 | 115篇 |
2005年 | 102篇 |
2004年 | 75篇 |
2003年 | 86篇 |
2002年 | 75篇 |
2001年 | 48篇 |
2000年 | 53篇 |
1999年 | 38篇 |
1998年 | 39篇 |
1997年 | 27篇 |
1996年 | 29篇 |
1995年 | 23篇 |
1994年 | 27篇 |
1993年 | 20篇 |
1992年 | 14篇 |
1991年 | 13篇 |
1990年 | 14篇 |
1989年 | 18篇 |
1988年 | 12篇 |
1987年 | 8篇 |
1986年 | 10篇 |
1985年 | 8篇 |
1984年 | 6篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有3060条查询结果,搜索用时 31 毫秒
41.
42.
《Expert opinion on pharmacotherapy》2013,14(16):2457-2467
Introduction: Generalized anxiety disorder (GAD) is a chronic, relapsing, debilitating disorder, associated with markedly impaired social and occupational functioning. Pharmacological treatment is considered standard care and several drug classes are now FDA approved for the treatment of GAD. While there are clear data for the efficacy of short-term acute treatment, long-term treatment and treatment-resistant GAD remain challenging. Areas covered: This article describes current pharmacological treatment options for GAD, with focus on benzodiazepines, azapirones, antidepressants and anticonvulsant and antipsychotic drugs. Recent findings from placebo-controlled clinical trials are reviewed and evidence-based clinical implications are discussed. A PubMed search was completed using the terms: ‘generalized anxiety disorder AND treatment’ and ‘generalized anxiety disorder AND therapy’. Additional pivotal trials were included for a historical perspective (older landmark trials that established efficacy and safety for older drug classes in the treatment of GAD). Expert opinion: Efficacy for treatment of GAD has been established for several different drug classes. At present, based on clear efficacy and good tolerability, first-line treatment with either a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI) is indicated. If an initial, at least moderate, clinical response is achieved under antidepressant therapy, treatment should be at least continued for 12 months. 相似文献
43.
《British journal of haematology》2017,177(2):221-225
Marizomib, a natural marine product, is an irreversible proteasome inhibitor currently under investigation in relapsed‐refractory multiple myeloma (RRMM) and malignant glioma. Central nervous system‐multiple myeloma (CNS‐MM) is a rare manifestation of extra‐medullary disease with few therapeutic options, highlighting the unmet clinical need in these patients. Marizomib demonstrated encouraging activity in RRMM and has emerging clinical activity in glioma, making it a potential CNS‐MM therapeutic intervention. Herein, we present two patients with RRMM and CNS involvement who benefited from marizomib‐based therapy. These cases provide the first proof of principle for further exploring marizomib in CNS‐MM patients. 相似文献
44.
The work of Robins and her colleagues on heroin addiction among Vietnam veterans sets out in microcosm many of the key factors that play out in the development and maintenance of substance addiction beyond the pharmacology of the drug: price, availability, the process of delivery of the addictive substance, availability of other substances, social norms, education and life circumstances. Robins' studies found high rates of heroin use (34%) and symptoms of heroin dependence (20%) among US soldiers while serving in Vietnam. In the first year after returning to the United States only 1% became re‐addicted to heroin, although 10% tried the drug after their return. Like other seminal studies, this work needs to be read in the original, because relying upon secondary interpretations risks being given a selectively edited version of their findings in service of varied policy and theoretical agendas. 相似文献
45.
Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT 下载免费PDF全文
46.
Chronological observation of surgically‐treated granuloma faciale implies the necessity of circumspect management for perinasal nodular subset 下载免费PDF全文
Yurie Shimoda‐Komatsu Misaki Kinoshita‐Ise Hiroaki Shimoyamada Manabu Ohyama 《The Journal of dermatology》2018,45(9):1122-1125
Granuloma faciale (GF) is a rare chronic dermatosis with still unknown etiopathology, which usually presents a solitary, asymptomatic, smooth reddish‐brown to violaceous plaques or nodules on the face. Various therapeutic approaches, including topical application of corticosteroid or tacrolimus and removal with laser, cryotherapy and surgery have been attempted; however, the outcome has been inconsistent. Herein, we report a case of perinasal nodular GF who repeatedly underwent surgical excisions after the failure of laser treatment. Despite its nomenclature, GF does not manifest granulomatous tissue and the lesion is histopathologically characterized by dense dermal cell infiltration devoid of granulomatous changes and not distinguished by a clear border, which partially explains the difficulty of complete removal in our case. Review of the published work delineated that GF could be largely divided into two clinical subsets: plaque and nodular types. The plaque type GF could be responsive to topical tacrolimus, an approach preferentially adopted nowadays, while nodular type GF was often resistant to topical therapies and required surgical or laser removal. The latter subset often arose around the nose. For this location, surgical excision with sufficient removal margin is sometimes technically difficult when an aesthetically acceptable outcome is expected, explaining the basis for local recurrence. Postoperative recurrence could be observed after years of disease‐free period. These observations indicated that the need for respective treatment strategies for the management of distinctive GF subsets. Of note, a multidisciplinary approach combining radical resection and additional supportive intervention with long‐term follow up may be required for perinasal and nodular GF. 相似文献
47.
Chelsey N. Torgerson 《Alcoholism treatment quarterly》2018,36(2):286-290
A major task for mental health professionals and group leaders that frequently work with clients working through sobriety and recovery is to develop new and creative ways to engage their clients with the same relevant information. Substance use recovery treatment standards are highlighted and expressive arts therapy is explored. By combining treatment standards with expressive arts therapy, the road map to recovery intervention is outlined. This tool is used to process recovery, identify triggers, develop coping strategies, and to further instill hope for a future of sobriety. 相似文献
48.
49.
Arnold C. Paulino 《Pediatric hematology and oncology》2013,30(1):81-86
Collins' law states that the period of risk for tumor recurrence is the age of the child at diagnosis plus 9 months. The purpose of this study is to validate this rule through a retrospective review of common pediatric tumors seen at 1 institution. Inclusion criteria for this study included an age at diagnosis of < 16 years old, minimum follow-up time of the Collins risk period (CRP) if child did not relapse and treatment with curative intent. The records of 424 children seen and treated for neuroblastoma (n = 98), Wilms tumor (n = 86), rhabdomyosarcoma (n = 82), medulloblastoma (n = 59), Ewing sarcoma (n = 43), ependymoma (n = 25), supratentorial PNET (n = 22), and synovial sarcoma (n = 9) from 1960 to 2001 were reviewed. CRP was calculated using the age of child at initial diagnosis plus 9 months. The median follow-up time was 164 months (range, 11–484 months), while the median follow-up/CRP ratio was 4.89 (range, 1.0–48.0). A total of 183 of 424 (43.2%) patients relapsed, with 180 (98.4%) relapses occurring during the CRP. Relapses beyond the CRP were seen in 3 young children (ages 7 months, 24 months, and 2 weeks at initial diagnosis) with a diagnosis of Wilms tumor (n = 2) and supratentorial PNET (n = 1) at 1, 3, and 26 months post-CRP. Collins' law is a useful and simple way of predicting risk period for relapse in the tumor types studied. 相似文献
50.
Lance Brendan Young Kathleen M. Grant R. Dario Pulido Jamie L. Simpson Kimberly A. Tyler Christine Timko 《Alcoholism treatment quarterly》2018,36(2):179-201
Community-based support group participation protects against substance use disorder (SUD) relapse, but referrals during treatment are inconsistently delivered and may not acknowledge barriers facing rural patients. This formative evaluation of a rural intensive referral intervention (RAIR) to community-based support groups for Veterans seeking SUD treatment surveyed patients (n = 145) and surveyed and interviewed treatment staff (n = 28). Patients and staff did not differ significantly on quantitative ratings of the helpfulness of, or satisfaction with, seven RAIR components, but staff did not deliver the intervention consistently or as designed, citing two themes: lack of commitment and lack of resources. 相似文献